Positive opinion issued to broaden use of Erbitux, including first-line colorectal cancer June 9, 2008 No Comments
CHMP issues positive opinion for icatibant in HAE; FDA issues not approvable letter April 28, 2008 No Comments
EMEA recommends that new warnings be included in product information for Novartis' Sebivo Feb. 19, 2008 No Comments
Lenalidomide approved in Australia and Canada, receives negative opinion in Europe Jan. 29, 2008 No Comments
EMEA recommends suspension of marketing authorization of medicines containing aprotinin Nov. 23, 2007 No Comments
Novartis withdraws application to extend marketing authorization for Zometa Nov. 22, 2007 No Comments
RSS